[Translated article] Influence of SARS-CoV-2 infection on the use of ceftazidime-avibactam in the critical patient
The SARS-CoV-2 pandemic did not lead to a change in the criteria for the use of ceftazidime-avibactam in the critically ill patient.
Authors
- José Manuel Caro Teller (ORCID: https://orcid.org/0000-0002-3043-653X)
- José Miguel Ferrari Piquero
- Fátima Mayo Olveira
- María Dolores Canales Siguero
- María del Carmen Jiménez León
- Sara Ortiz Pérez
Institutions
- Hospital Universitario 12 De Octubre (ES)
Publication Details
- Journal
- Farmacia Hospitalaria
- Published
- 2025-09-23
- DOI
- https://doi.org/10.1016/j.farma.2025.03.016
- Primary Topic
- Antibiotic Use and Resistance
- Type
- article
- Field-Weighted Citation Impact
- 0.00